Home LiteratureArticle Details
PMID: 21552859 Published · ppublish English Journal Article

Suppression and restoration of v-SRC expression in rsv transformed-cells after transfection with N-ras and its antagonist.

International journal of oncology ·Vol. 7 ·No. 3 ·1995-09-00 ·页码 453-9

Tchevkina E, Kisseljova N, Shtutman M, Musatkina E, Mizenina O, Leskov K, Tavitian A, Kisseljov F

Abstract

Previously, it was shown that hamster cells transformed by Rous Sarcoma Virus (RSV) exhibited a decreased expression of the RSV products (including the pp60 src oncogene) when these cells were supertransfected with the N-ras oncogene. To assess the responsibility of the activated N-ras in the modulation of the RSV viral products, a strategy based on two ras antagonists was used; i.e. i) a rap1A/K-rev1 expression vector known for its capacity to revert the K-ras induced transformed phenotype and ii) a plasmid containing antisense N-ras sequence. We present data showing only the plasmid construct containing the N-ras antisense sequense could inhibit expression or N-ras and, at the same time, restore the expression of v-src, up to a level comparable to that of the parental cells. Our results support the idea that some biological switches, triggered and activated through the N-ras oncogene pathway, might modulate the promoter activity of the RSV LTR.

作者与单位
共 8 位作者,点击展开单位 / ORCID
Tchevkina E
CTR CANC RES,INST CARCINOGENESIS,MOSCOW,RUSSIA. INSERM,U248,F-75010 PARIS,FRANCE.
Kisseljova N
Shtutman M
Musatkina E
Mizenina O
Leskov K
Tavitian A
Kisseljov F
Article Info
Journal
International journal of oncology
Abbr.
Int J Oncol
ISSN
1019-6439
Published
1995-09-00
页码
453-9
Language
English
Country/Region
Greece
NLM ID
9306042
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com